ClinicalTrials.gg

Program

iron isomaltoside 1000

Also written as “Iron isomaltoside 1000”, “Iron isomaltoside/ferric derisomaltose” and “Monofer”.

Its studies are mostly in Anemia, Iron-Deficiency · Inflammatory Bowel Diseases · Renal Insufficiency, Chronic · Iron Deficiencies · Postpartum Hemorrhage, led by 2 companies.

Furthest: phase 4, since Jun 13, 201730 company-led studies, 3 open or runningNext primary completion: Apr 30, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pharmacosmos292 open or runningphase 4since Jun 13, 2017Sep 27, 2007Apr 30, 2027phase 3 · NCT05179226
Sichuan Huiyu Pharmaceutical11 open or runningphase 1since Jul 27, 2026Jul 27, 2026none ahead

Also a collaborator on its studies: Boji Medical Technology, BioStata, ClinStar, Laboratory Corporation of America and ClinSmart.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 12 studies since Sep 27, 2007.

  1. Apr 25, 2012Phase 3 study in Inflammatory Bowel DiseasesPharmacosmos · NCT01599702 · 21 enrolled · Denmark
  2. Jun 26, 20133 phase 3 studiesPharmacosmos · NCT01895231, NCT01895218, NCT01895205
  3. Apr 28, 2014Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02130063 · 511 enrolled · United States
  4. Jun 21, 2014Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02172001 · United States
  5. Mar 30, 2015Phase 2 study in Restless Legs SyndromePharmacosmos · NCT02484768
  6. Sep 27, 20162 phase 3 studies in Anemia, Iron-DeficiencyPharmacosmos · NCT02940886, NCT02940860
  7. Nov 9, 2016Phase 3 study in Anemia, Iron-DeficiencyPharmacosmos · NCT02962648 · 103 enrolled · United States
  8. Dec 22, 2016Phase 1 study in AnemiaPharmacosmos · NCT03013439 · 24 enrolled · Japan
  9. Jun 13, 2017Phase 4 study in Iron Deficiency Anemia of PregnancyPharmacosmos · NCT03188445 · 201 enrolled · Denmark
  10. Jul 6, 20172 phase 3 studies in Anemia, Iron-DeficiencyPharmacosmos · NCT03238911, NCT03237065
  11. Mar 6, 2018Phase 4 study in IBDPharmacosmos · NCT03466983 · 97 enrolled · Denmark
  12. Nov 16, 2021Phase 3 study in Iron DeficienciesPharmacosmos · NCT05179226 · 200 planned · United States
  13. Apr 8, 2025Phase 3 study in Iron DeficienciesPharmacosmos · NCT06929806 · 1,900 planned · United States
  14. Jul 27, 2026Sichuan Huiyu Pharmaceutical’s first study: phase 1 study in Anemia, Iron-DeficiencyNew to Sichuan Huiyu PharmaceuticalSichuan Huiyu Pharmaceutical · NCT07790562 · 88 planned · China

Ahead

  1. Apr 30, 2027Primary completion: phase 3 study in Iron DeficienciesPharmacosmos · NCT05179226
  2. Dec 1, 2027Primary completion: phase 3 study in Iron DeficienciesPharmacosmos · NCT06929806

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 30 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07790562Anemia, Iron-Deficiency · China1RecruitingSichuan Huiyu PharmaceuticalSep 29, 202688
NCT06929806Iron Deficiencies · United States3RecruitingPharmacosmosDec 1, 20271,900
NCT05179226Iron Deficiencies · United States3RecruitingPharmacosmosApr 30, 2027200
NCT03466983IBD · Denmark4CompletedPharmacosmosMay 25, 202097
NCT03238911Anemia, Iron-Deficiency · United States3CompletedPharmacosmosJun 19, 2018123
NCT03237065Anemia, Iron-Deficiency · United States3CompletedPharmacosmosMay 29, 2018122
NCT03188445Iron Deficiency Anemia of Pregnancy · Denmark4CompletedPharmacosmosJun 26, 2020201
NCT03013439Anemia · Japan1CompletedPharmacosmosJun 4, 201724
NCT02962648Anemia, Iron-Deficiency · United States3CompletedPharmacosmosJun 12, 2018103
NCT02940886Anemia, Iron-Deficiency · United States3CompletedPharmacosmosMar 28, 20181,512
NCT02940860Anemia, Iron-Deficiency · United States3CompletedPharmacosmosMay 29, 20181,538
NCT02484768Restless Legs Syndrome2WithdrawnPharmacosmosFeb 20150
NCT02172001Anemia, Iron-Deficiency · United States3WithdrawnPharmacosmosMar 20150
NCT02130063Anemia, Iron-Deficiency · United States3CompletedPharmacosmosAug 2015511
NCT01895231Anemia, Iron-Deficiency · Denmark3CompletedPharmacosmosDec 2016107
NCT01895218Postpartum Hemorrhage · Denmark3CompletedPharmacosmosDec 2014200
NCT01895205Postpartum Hemorrhage · Denmark3CompletedPharmacosmosAug 201513
NCT01599702Inflammatory Bowel Diseases · Denmark3CompletedPharmacosmosDec 201421
NCT01563367Anemia · Denmark3CompletedPharmacosmosAug 201374
NCT01469078Renal Insufficiency, Chronic1CompletedPharmacosmosApr 201218
NCT01410435Inflammatory Bowel Diseases · Austria, Hungary3CompletedPharmacosmosAug 201339
NCT01280240Anemia · United States1CompletedPharmacosmosSep 201211
NCT01222884Renal Insufficiency, Chronic · India3CompletedPharmacosmosOct 2013351
NCT01213992Non-dialysis Dependent Chronic Kidney Disease1CompletedPharmacosmosOct 201216
NCT01213680Inflammatory Bowel Diseases1CompletedPharmacosmosAug 201216
NCT01145638Neoplasms · India3CompletedPharmacosmosApr 2014350
NCT01102413Anemia, Iron-Deficiency · Denmark3CompletedPharmacosmosJun 2014351
NCT01017614Inflammatory Bowel Diseases · Denmark, India, United Kingdom3CompletedPharmacosmosJul 2012350
NCT00537186Heart Failure · Denmark3CompletedPharmacosmosJul 200820
NCT00536666Renal Insufficiency, Chronic · Denmark3CompletedPharmacosmosAug 2008182

How it is read

Names in the registry

  • “Iron isomaltoside 1000”, 6 entries
  • “Iron isomaltoside/ferric derisomaltose”, 5 entries
  • “Monofer”, 5 entries
  • “Ferric Derisomaltose”, 2 entries
  • “Iron Isomaltoside”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.